Orlando, Elena J.
Han, Xia
Tribouley, Catherine
Wood, Patricia A.
Leary, Rebecca J.
Riester, Markus http://orcid.org/0000-0002-4759-8332
Levine, John E.
Qayed, Muna
Grupp, Stephan A.
Boyer, Michael
De Moerloose, Barbara
Nemecek, Eneida R.
Bittencourt, Henrique
Hiramatsu, Hidefumi
Buechner, Jochen
Davies, Stella M.
Verneris, Michael R.
Nguyen, Kevin
Brogdon, Jennifer L.
Bitter, Hans
Morrissey, Michael
Pierog, Piotr http://orcid.org/0000-0001-6711-4107
Pantano, Serafino
Engelman, Jeffrey A.
Winckler, Wendy
Article History
Received: 13 February 2018
Accepted: 3 July 2018
First Online: 1 October 2018
Competing interests
: The research samples used in this manuscript come from patients treated on clinical trials conducted by Novartis. J.E.L., M.Q., H. Bittencourt, S.M.D, and S.A.G. consult for Novartis. E.J.O., X.H., C.T., P.A.W., R.J.L., M.R., J.L.B., H.Bitter, M.M., P.P., S.P., J.A.E., and W.W. are employed by Novartis or were employed by Novartis at the time of manuscript preparation.